Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA: Indian Drug Company Failed to Meet U.S. Standards

The warning letter included two of the company's facilities.

The FDA recently issued a warning letter to India-based generic drug company, Cadila Healthcare, for failing to meet the regulatory standards of the U.S., reported Chemical & Engineering News.

Although the FDA has not made the letter public yet, the report said that the company told the Bombay Stock Exchange, in a statement, that the letter covered, "two plants, one making active pharmaceutical ingredients and the other formulations."

It was not immediately clear what the violations were.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?